1. Pink Sheet

Payers, Medical Journals Could Help Push For Clinical Trial Diversity, Cavazzoni Says

 
• By Derrick Gingery

The director of the US FDA’s Center for Drug Evaluation and Research acknowledged that the FDA cannot improve trial diversity alone.

diversity
CDER Director Patrizia Cavazzoni also said the agency must implement diversity requirements without making drug development too difficult. • Source: Shutterstock

The US Food and Drug Administration is preparing to implement new clinical trial diversity requirements, but Center for Drug Evaluation and Research Director Patrizia Cavazzoni believes other stakeholders could help ensure sponsors test new drugs in all relevant populations.

“There is a potential place for medical journals,” she said 8 January during a session on clinical trial diversity at the 2023 Innovations in Regulatory Science Summit

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Clinical Trials

More from R&D